Clinical trial

Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN

NCT02642562

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Ferric Derisomaltose Normalized identity: ferric derisomaltoseView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-08-01

PhasePHASE4

Conditions

Chronic Heart Failureunresolved

Iron Deficiencyunresolved

Left Ventricular Systolic Dysfunctionunresolved

Interventions

Ferric DerisomaltoseDRUG · verified · RxNorm: ferric derisomaltose

Sponsors & collaborators

University of Glasgowlead sponsor

NHS Greater Glasgow and Clydecollaborator

Pharmacosmos A/Scollaborator

British Heart Foundationcollaborator

Mapped research locations

LondonUnited Kingdom6 GlasgowUnited Kingdom3 ManchesterUnited Kingdom2 LiverpoolUnited Kingdom2 NottinghamUnited Kingdom1 SheffieldUnited Kingdom1 EdinburghUnited Kingdom1 LeicesterUnited Kingdom1 OxfordUnited Kingdom1 BristolUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02642562 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.